Anticancer agents : frontiers in cancer chemotherapy /
Annotation
| Corporate Authors: | , , |
|---|---|
| Other Authors: | , , |
| Format: | eBook |
| Language: | English |
| Language Notes: | English. |
| Published: |
Washington, DC :
American Chemical Society,
©2001.
|
| Series: | ACS symposium series ;
796. |
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
Table of Contents:
- Cancer drug discovery and development : new paradigms for a new millennium / E.A. Sausville [and others]
- Evolutionary biosynthesis of anticancer drugs / George R. Pettit
- Some recent developments in the synthesis and structure-activity relationship of novel taxanes / John F. Kadow [and others]
- New generation taxoids and hybrids of microtubule-stabilizing anticancer agents / Iwao Ojima [and others]
- Discodermolide and taxol : a synergistic drug combination in human carcinoma cell lines / Susan Band Horwitz [and others]
- Highly efficient semisynthesis of biologically active epothilone derivatives / Gregory D. Vite [and others]
- Synthetic and semisynthetic analogs of epothilones : chemistry and biological activity / Karl-Heinz Altmann [and others]
- Synthesis and biological activity of epothilones / Ulrich Klar [and others]
- Epothilones and sarcodictyins : from combinatorial libraries to designed analogs / Nicolas Winssinger and K.C. Nicolaou
- Synthesis and structure-activity relationship studies of cryptophycins : a novel class of potent antimitotic antitumor depsipeptides / Chuan Shih [and others]
- Farnesyltransferase inhibitors as potential anticancer agents / J.B. Gibbs [and others]
- Farnesyltransferase inhibitors : from squalene synthase inhibitors to the clinical agent BMS-214662 / John T. Hunt
- Inhibiting farnesyl protein transferase with Sch-66336 : potentially a selective noncytotoxic therapy for human cancer / A.G. Taveras [and others]
- Pyrrolo[2,3-d]pyrimidine and pyrazolo[3,4-d]pyrimidine derivatives as selective inhibitors of the EGF receptor tryosine kinase / G. Caravatti [and others]
- STI571 : a new treatment modality for CML? / Jürg Zimmermann, Pascal Furet, and Elisabeth Buchdunger
- The discovery and development of second-generation matrix metalloproteinase inhibitors for the treatment of cancer / Andy Baxter and John Montana
- Prospects for antiangiogenic therapies based upon VEGF inhibition / Pascal Furet and Paul W. Manley
- Carbohydrate-based tumor antigens as antitumor vaccine agents / Jennifer R. Allen and Samuel J. Danishefsky
- Drugs to enhance the therapeutic potency of anticancer antibodies : antibody-drug conjugates as tumor-activated prodrugs / Walter A. Blättler and Ravi V.J. Chari.